AU2021903144A0 - Antibody and peptide conjugates, therapeutic peptides and uses thereof - Google Patents

Antibody and peptide conjugates, therapeutic peptides and uses thereof

Info

Publication number
AU2021903144A0
AU2021903144A0 AU2021903144A AU2021903144A AU2021903144A0 AU 2021903144 A0 AU2021903144 A0 AU 2021903144A0 AU 2021903144 A AU2021903144 A AU 2021903144A AU 2021903144 A AU2021903144 A AU 2021903144A AU 2021903144 A0 AU2021903144 A0 AU 2021903144A0
Authority
AU
Australia
Prior art keywords
antibody
peptide conjugates
therapeutic peptides
peptides
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021903144A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Envision Sciences Pty Ltd
Original Assignee
Envision Sciences Pty Ltd
Filing date
Publication date
Application filed by Envision Sciences Pty Ltd filed Critical Envision Sciences Pty Ltd
Publication of AU2021903144A0 publication Critical patent/AU2021903144A0/en
Pending legal-status Critical Current

Links

AU2021903144A 2021-10-01 Antibody and peptide conjugates, therapeutic peptides and uses thereof Pending AU2021903144A0 (en)

Publications (1)

Publication Number Publication Date
AU2021903144A0 true AU2021903144A0 (en) 2021-10-14

Family

ID=

Similar Documents

Publication Publication Date Title
EP3958910A4 (en) Anti-cd45 antibody drug conjugates and uses thereof
AU2021311470A1 (en) Binding proteins recognizing SARS-CoV-2 antigens and uses thereof
WO2007019865A3 (en) Therapy with cd4 binding peptides and radiation
EP4069274A4 (en) Peptide conjugates and methods of use
EP4105227A4 (en) Immune checkpoint tim3-targeting binding peptide and application thereof
EP3774923A4 (en) Drug conjugates of cmet monoclonal binding agents, and uses thereof
IL309360A (en) Peptide drug conjugates
EP3909975A4 (en) Novel polypeptide and therapeutic uses thereof
EP3676250A4 (en) Peptide conjugates, conjugation process, and uses thereof
EP3999544A4 (en) Polypeptide complex for conjugation and use thereof
EP4190802A4 (en) Cell-penetrating peptide and use thereof
TWI800861B (en) Fusion protein comprising anti-lag-3 antibody and il-2, and use thereof
EP4146671A4 (en) Novel protein, and therapeutic and cosmetic uses thereof
EP4141020A4 (en) Novel cell-penetrating peptide and use thereof
AU2021903144A0 (en) Antibody and peptide conjugates, therapeutic peptides and uses thereof
AU2020903537A0 (en) Antibody and peptide conjugates, therapeutic peptides and uses thereof
EP3976104A4 (en) Anti-csf1r antibodies, il10 fusion proteins, and uses thereof
EP3917572A4 (en) Monoclonal antibodies against mhc-bound human dickkopf-1 peptides and uses thereof
WO2022221479A3 (en) Magec2 immunogenic peptides, binding proteins recognizing magec2 immunogenic peptides, and uses thereof
EP4132554A4 (en) Anti-obesity peptides and uses thereof
EP4209500A4 (en) Peptide, and cosmetic composition and pharmaceutical composition comprising same
EP3932912A4 (en) Protein and/or peptide modification molecule
EP4107530A4 (en) Peptide and protein c-terminus labeling
AU2023902602A0 (en) Peptide conjugates and uses thereof
EP3983446A4 (en) Conditionally active anti-epcam antibodies, antibody fragments, their immunoconjugates and uses thereof